We are:
- Clinical Stage Biotechnology Company Specializing in Human Vaccines
- Creating, Developing, Manufacturing & Testing Innovative HIV/AIDS Vaccines
- Conducting Multiple Site Phase 1 HIV/AIDS Human Clinical Vaccine Trials
Our AIDS Vaccines:
- Are Designed for Predominant AIDS Virus Subtypes
- Use DNA & Viral Vector Technologies
- Demonstrated Excellent Preclinical Data: 96% Protection in Non-Human Primates
- Completed Satisfactory Phase 1 Human Trial
- DNA & MVA Human Trials Stimulating Immune Responses
Our Business:
- Vaccines: The Most Cost Effective Way to Combat Infectious Disease
- Large Global AIDS Vaccine Market = >$4 Billion
- Customers: Humans - All Ages, Sexes, Races, Nationalities, Geographical Regions
- People with AIDS in 2006 is estimated at 39.5 Million